Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High Incidence of Herpes Zoster in Nonmyeloablative Hematopoietic Stem Cell Transplantation

26 Oct 2010

Abstract excerpt

Although the use of nonmyeloablative (NMA) hematopoietic stem cell transplantation (HSCT) regimens has expanded in the past decade, little data exist to support antiviral prophylaxis to prevent herpes zoster (HZ) in recipients who are seropositive for varicella-zoster virus in this population. The present study examined the clinical features, incidence, and risk factors for HZ in a homogeneous cohort of NMA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus and herpesvirus research
Share to Herpesvirus Infections and Treatments
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20977944
DOI: 10.1016/j.bbmt.2010.10.025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High Incidence of Herpes Zoster in Nonmyeloablative Hematopoietic Stem Cell TransplantationPMID 20977944Read ↗

Viral reactivations following hematopoietic stem cell transplantation in pediatric patients – A single center 11-year analysisSemantic proximity Read ↗

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantationSemantic proximity Read ↗

The Complex Relationship between Human Herpesvirus 6 and Acute Graft-versus-Host DiseaseSemantic proximity Read ↗

Early Human Herpesvirus Type 6 Reactivation after Allogeneic Stem Cell Transplantation: A Large-Scale Clinical StudySemantic proximity Read ↗

Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantationSemantic proximity Read ↗

Cord-Blood Hematopoietic Stem Cell Transplant Confers an Increased Risk for Human Herpesvirus-6-Associated Acute Limbic Encephalitis: A Cohort AnalysisSemantic proximity Read ↗

Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan: a retrospective multicenter studySemantic proximity Read ↗

Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxisSemantic proximity Read ↗

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationSemantic proximity Read ↗

Long‐term ultra‐low‐dose acyclovir against varicella‐zoster virus reactivation after allogeneic hematopoietic stem cell transplantationSemantic proximity Read ↗

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbiditiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.